Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

ClinicalTrials.gov ID: NCT05254457

Public ClinicalTrials.gov record NCT05254457. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Open-Label, Extension Study to Evaluate the Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

Study identification

NCT ID
NCT05254457
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Endo USA Inc., a Keenova Therapeutics Company
Industry
Enrollment
145 participants

Conditions and interventions

Interventions

  • EN3835 Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 13, 2022
Primary completion
Mar 20, 2024
Completion
Mar 20, 2024
Last update posted
Mar 20, 2025

2022 – 2024

United States locations

U.S. sites
27
U.S. states
11
U.S. cities
25
Facility City State ZIP Site status
Endo Clinical Trial Site #12 Bakersfield California 19331
Endo Clinical Trial Site #3 Fresno California 93710
Endo Clinical Trial Site #23 La Mesa California 91942
Endo Clinical Trial Site #13 Tarzana California 91356
Endo Clinical Trial Site #15 Vista California 92083
Endo Clinical Trial Site #18 Whittier California 90603
Endo Clinical Trial Site #24 Miami Florida 33176
Endo Clinical Trial Site #8 Pinellas Park Florida 33782
Endo Clinical Trial Site #21 Sweetwater Florida 33172
Endo Clinical Trial Site #22 Lawrenceville Georgia 30043
Endo Clinical Trial Site #25 Meridian Idaho 83642
Endo Clinical Trial Site #19 Decatur Illinois 62521
Endo Clinical Trial Site #2 O'Fallon Illinois 62269
Endo Clinical Trial Site #14 Springfield Illinois 62704
Endo Clinical Trial Site #6 Pasadena Maryland 21122
Endo Clinical Trial Site #16 Jefferson City Missouri 65109
Endo Clinical Trial Site #9 York Pennsylvania 17402
Endo Clinical Trial Site #4 Bedford Texas 76021
Endo Clinical Trial Site #17 Dallas Texas 75208
Endo Clinical Trial Site #26 Dallas Texas 75251
Endo Clinical Trial Site #5 Fort Worth Texas 76104
Endo Clinical Trial Site #27 Georgetown Texas 78628
Endo Clinical Trial Site #7 Houston Texas 77027
Endo Clinical Trial Site #10 Houston Texas 77095
Endo Clinical Trial Site #1 McAllen Texas 78501
Endo Clinical Trial Site #11 Salt Lake City Utah 84107
Endo Clinical Trial Site #20 Suffolk Virginia 23434

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05254457, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 20, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05254457 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →